EP2049105A4 - Anti-microbial photodynamic therapy - Google Patents
Anti-microbial photodynamic therapy Download PDFInfo
- Publication number
- EP2049105A4 EP2049105A4 EP07797049.9A EP07797049A EP2049105A4 EP 2049105 A4 EP2049105 A4 EP 2049105A4 EP 07797049 A EP07797049 A EP 07797049A EP 2049105 A4 EP2049105 A4 EP 2049105A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- photodynamic therapy
- microbial
- microbial photodynamic
- therapy
- photodynamic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000000845 anti-microbial effect Effects 0.000 title 1
- 239000004599 antimicrobial Substances 0.000 title 1
- 238000002428 photodynamic therapy Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Radiation-Therapy Devices (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83383606P | 2006-07-27 | 2006-07-27 | |
US11/880,974 US20090030257A1 (en) | 2007-07-25 | 2007-07-25 | Anti-microbial photodynamic therapy |
PCT/US2007/016951 WO2009014524A2 (en) | 2006-07-27 | 2007-07-27 | Anti-microbial photodynamic therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2049105A2 EP2049105A2 (en) | 2009-04-22 |
EP2049105A4 true EP2049105A4 (en) | 2022-03-30 |
Family
ID=40282008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07797049.9A Withdrawn EP2049105A4 (en) | 2006-07-27 | 2007-07-27 | Anti-microbial photodynamic therapy |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2049105A4 (en) |
BR (1) | BRPI0714667A8 (en) |
MX (1) | MX2009001074A (en) |
WO (1) | WO2009014524A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114641313A (en) * | 2019-08-02 | 2022-06-17 | 科伊特健康有限公司 | Method for enhancing antimicrobial action of systemically administered antibiotics |
CN114053406B (en) * | 2021-11-23 | 2022-12-09 | 华中科技大学 | Multifunctional photo-thermal nano sterilization material and preparation and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6462070B1 (en) * | 1997-03-06 | 2002-10-08 | The General Hospital Corporation | Photosensitizer conjugates for pathogen targeting |
US20040186087A1 (en) * | 2003-03-20 | 2004-09-23 | Ceramoptec Industries, Inc. | Siderophore conjugates of photoactive dyes for photodynamic therapy |
US20050281777A1 (en) * | 2004-06-18 | 2005-12-22 | Ceramoptec Industries, Inc. | Photo-triggered release of active substances from dendrimer-photosensitizer complexes |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030215421A1 (en) * | 1999-07-21 | 2003-11-20 | Mcdonald John R. | Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
EP1610751A4 (en) * | 2001-04-26 | 2006-05-24 | Univ Texas | Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use |
US20030176326A1 (en) * | 2002-03-15 | 2003-09-18 | Ceramoptec Industries Inc. | Photosensitzers for photodynamic therapy of microbial infections |
JP2007521338A (en) * | 2004-01-07 | 2007-08-02 | アンビット バイオサイエンシス コーポレーション | Conjugated small molecule |
-
2007
- 2007-07-27 BR BRPI0714667A patent/BRPI0714667A8/en not_active Application Discontinuation
- 2007-07-27 EP EP07797049.9A patent/EP2049105A4/en not_active Withdrawn
- 2007-07-27 WO PCT/US2007/016951 patent/WO2009014524A2/en active Application Filing
- 2007-07-27 MX MX2009001074A patent/MX2009001074A/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6462070B1 (en) * | 1997-03-06 | 2002-10-08 | The General Hospital Corporation | Photosensitizer conjugates for pathogen targeting |
US20040186087A1 (en) * | 2003-03-20 | 2004-09-23 | Ceramoptec Industries, Inc. | Siderophore conjugates of photoactive dyes for photodynamic therapy |
US20050281777A1 (en) * | 2004-06-18 | 2005-12-22 | Ceramoptec Industries, Inc. | Photo-triggered release of active substances from dendrimer-photosensitizer complexes |
Also Published As
Publication number | Publication date |
---|---|
BRPI0714667A8 (en) | 2016-10-18 |
MX2009001074A (en) | 2009-06-05 |
EP2049105A2 (en) | 2009-04-22 |
WO2009014524A3 (en) | 2020-10-15 |
BRPI0714667A2 (en) | 2013-08-06 |
WO2009014524A2 (en) | 2009-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1219911A1 (en) | Ocular radiosurgery | |
EP1989185B8 (en) | Therapeutic compounds | |
IL196559A0 (en) | Combination therapy | |
EP2960233B8 (en) | New therapeutic agents | |
ZA200807934B (en) | Cancer treatments | |
HK1205935A1 (en) | Non-lithotripsic kidney-stone therapy | |
WO2007082127A8 (en) | Combination therapy for long-lasting ckrtm | |
EP2073891A4 (en) | Pacemaker | |
IL196556A0 (en) | Combination therapy | |
EP2054061A4 (en) | Combination therapy | |
AU2008263581A8 (en) | Well treatment | |
EP2010570B8 (en) | Therapy against cathepsin s | |
ZA200902203B (en) | Combination therapy | |
EP2049105A4 (en) | Anti-microbial photodynamic therapy | |
GB0606660D0 (en) | Targeted Therapy | |
AU2006902723A0 (en) | Therapeutic treatment | |
AU2007903369A0 (en) | Therapeutic Agents | |
AU2006901059A0 (en) | Therapeutic Agents | |
AU2006905623A0 (en) | Treatment | |
AU2006100583A4 (en) | Treatment Planning Made Easy | |
AU2008903284A0 (en) | Combination therapy | |
AU2006902304A0 (en) | Eye treatment | |
AU2008902703A0 (en) | Therapeutic agents | |
AU2008902139A0 (en) | HLST Therapy | |
GB0609414D0 (en) | Therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BIOLITEC PHARMA IP & INVESTMENT LTD. |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BIOLITEC UNTERNEHMENSBETEILIGUNGS II AG |
|
R17D | Deferred search report published (corrected) |
Effective date: 20201015 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210415 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61K0031407000 Ipc: A61K0041000000 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20220225 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 31/04 20060101ALI20220221BHEP Ipc: A61K 31/407 20060101ALI20220221BHEP Ipc: A61K 47/64 20170101ALI20220221BHEP Ipc: A61K 41/00 20060101AFI20220221BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20240201 |